Kidney function and future risk of atherosclerotic cardiovascular disease: a study from, approximately half million adults
Event: ESC Congress 2023
Topic: Epidemiology
Session: Risk factors and prevention: epidemiology (1)
Medical therapy for patients presenting with acute heart failure in emergency departments in a large integrated healthcare system.
Event: Heart Failure 2023
Topic: Epidemiology, Prognosis, Outcome
Session: Acute heart failure - epidemiology, prognosis, outcome 2
Risk of atherosclerotic cardiovascular disease in patients with premature ASCVD: A study from approximately 1 million young adults
Event: ESC Preventive Cardiology 2023
Topic: Epidemiology
Session: Moderated ePoster 22
Risk of cardiovascular events in a population with type 2 diabetes and metabolic dyslipidemia without atherosclerotic cardiovascular disease receiving statin therapy
Event: EuroPrevent 2018
Topic: Epidemiology
Session: Moderated Poster Session III
Risk of incident atherosclerotic cardiovascular disease events by atherogenic lipid levels in a real-world population of 62,428 on-statin individuals with diabetes
Event: ESC Congress 2017
Topic: Lipids (Epidemiology and Prevention)
Session: Lipid lowering therapy in primary cardiovascular prevention
Prevalence of elevated LDL- cholesterol and the risk of cardiovascular events in a population with established atherosclerotic cardiovascular disease, type 2 diabetes and metabolic dyslipidemia
Event: ESC Congress 2016
Topic: Epidemiology, lipids
Session: Cardiovascular risk in populations
ESC 365 is supported by
